Why Is ALAMAR BIOSCIENCES I (ALMR) Stock Moving Today?
By the Top Tier Newswire AI Desk · September 2, 2026 at 9:48 AM ET · reviewed against 2 wire stories
ALAMAR BIOSCIENCES I (ALMR) is drawing unusual attention today. Our newswire has captured 2 stories on ALMR across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 53/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why ALMR stock is moving today
Alamar Biosciences stock is moving higher in the early part of the session after the company announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference. The stock opened with a 0.8% gap up from the previous close and reached a session high of $31.29 within the first 15 minutes of trading. The move follows a recent SEC 8-K filing disclosing changes in certain officer compensatory arrangements.
What Happened
Alamar Biosciences announced on September 1, 2026, that it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference. This event is expected to provide visibility for the company as it continues to advance its precision proteomics platform for early disease detection. The same day, the company filed a Form 8-K with the SEC under Item 5.02, disclosing the departure or appointment of certain officers and related compensatory arrangements. These developments have drawn investor attention and contributed to the stock's early session strength.
What The Data Shows
Intraday volume remains muted at 0.0M shares traded, which is 0.0x the 3-month daily average. The stock last traded at $31.23, up from an opening price of $29.60. ALMR is currently trading within its 52-week range of $18.84 to $38.54. The company has a market cap of $2.1B and reported a revenue increase of 195.2% in the trailing twelve months despite an unprofitable EPS of -2.10 and a net margin of -49.5%. The stock printed two fresh 52-week highs on September 2, 2026, indicating continued investor optimism.
What To Watch
Investors should monitor the company's upcoming participation in the Morgan Stanley conference for potential updates on its business strategy and product pipeline. Additionally, the broader coverage of healthcare stocks in the coming sessions may influence ALMR's momentum.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
ALMR · Sep 2 session (5-min) · +3.85% vs prior close · updated 8:45 PM ETAI sentiment, last 36h · averaged over 2 stories · 53/100 neutral
The headlines behind the move
Story flow · 2 stories on the wire, last 36h · hover or tap a dot for the headline
11d agoBusiness InsiderBULLISH 56General
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
FREMONT, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced the company will be participating in the...
11d agoSEC 8-KNEUTRAL 50General
Alamar Biosciences, Inc. (ALMR) files 8-K
Filed: 2026-09-01 AccNo: 0001193125-26-378360 Size: 137 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →